Folic Acid Effects on S-Adenosylmethionine, S-Adenosylhomocysteine, and DNA Methylation in Patients with Intermediate Hyperhomocysteinemia

Journal of the American College of Nutrition

Volumn 30, Issue 1, 2011, Pages 11-18

  Pizzolo, Francesca ^a   Blom, Henk J ^b   Choi, Sang W ^c   Girelli, Domenico ^a   Guarini, Patrizia ^a   Martinelli, Nicola ^a   Stanzial, Anna Maria ^a   Corrocher, Roberto ^a   Olivieri, Oliviero ^a   Friso, Simonetta ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TUFTS UNIVERSITY   (United States)

Author keywords

DNA methylation; Folic acid supplementation; One carbon metabolism

Indexed keywords

DNA; FOLIC ACID; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA METHYLATION; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PROTEIN BLOOD LEVEL;

ADULT; AGED; DIETARY SUPPLEMENTS; DNA METHYLATION; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; VITAMIN B COMPLEX;

EID: 79960353621     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2011.10719939     Document Type: Article

References (47)

1. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050, 1998.
2. Finkelstein JD: Methionine metabolism in mammals. J Nutr Biochem 1:228-237, 1990.
3. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg ICH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-2698, 1993.
4. Homocysteine Lowering Trialists' Collaboration: Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82:806-812, 2005.
5. Kramer DL, Porter CW, Borchardt RT, Sufrin JR: Combined modulation of S-adenosylmethionine biosynthesis and S-adenosylhomocysteine metabolism enhances inhibition of nucleic acid methylation and L1210 cell growth. Cancer Res 50:3838-3842, 1990.
6. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ: Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275:29318-29323, 2000.
7. Lentz SR: Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3:1646-1654, 2005.
8. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, Blom HJ, Jakobs C, Tavares de Almeida I: Increased homocys-teine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49:1292-1296, 2003.
9. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA: Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132:2361S-2366S, 2002.
10. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C: Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 74:723-729, 2001.
11. Jamaluddin MD, Chen I, Yang F, Jiang X, Jan M, Liu X, Schafer AI, Durante W, Yang X, Wang H: Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 110:3648-3655, 2007.
12. Perna AF, Ingrosso D, De Santo NG, Galletti P, Brunone M, Zappia V: Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia. J Am Soc Nephrol 8:1899-1905, 1997.
13. Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML, Vacca M, D'Esposito M, D'Urso M, Galletti P, Zappia V: Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361:1693-1699, 2003.
14. Stam F, van Guldener C, ter Wee PM, Kulik W, Smith DE, Jakobs C, Stehouwer CD, de Meer K: Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine. Am J Physiol Renal Physiol 287:F215-F223, 2004.
15. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB: Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr 72:998-1003, 2000.
16. Shelnutt KP, Kauwell GP, Gregory JF III, Maneval DR, Quinlivan EP, Theriaque DW, Henderson GN, Bailey LB: Methylenetetrahydrofolate reductase 677C.T polymorphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem 15:554-560, 2004.
17. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R: Relation between folate status. a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation 93:7-9, 1996.
18. Girelli D, Friso S, Trabetti E, Olivieri O, Russo C, Pessotto R, Faccini G, Pignatti PF, Mazzucco A, Corrocher R: Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 91:4158-4163, 1998.
19. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J: A common mutation in the 5.10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 99:5606-5611, 2002.
20. Axume J, Smith SS, Pogribny IP, Moriarty DJ, Caudill MA: The MTHFR 677TT genotype and folate intake interact to lower global leukocyte DNA methylation in young Mexican American women. Nutr Res 27:13-17, 2007.
21. Pastore A, De Angelis S, Casciani S, Ruggia R, Di Giovamberardino G, Noce A, Splendiani G, Cortese C, Federici G, Dessi M: Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes. Clin Chem 52:145-148, 2006.
22. Friso S, Choi SW, Dolnikowski GG, Selhub J: A method to assess genomic DNA methylation using high-performance liquid chromatography/ electrospray ionization mass spectrometry. Anal Chem 74:4526-4531, 2002.
23. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52, 1987.
24. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R: Identification of a candidate genetic risk factor for vascular disease: a common mutation at the methylenetetrahydrofolate reductase locus. Nat Genet 10:111-113, 1995.
25. Gellekink H, van Oppenraaij-Emmerzaal D, van Rooij A, Struys EA, den Heijer M, Blom HJ: Stable-isotope dilution liquid chromatography-electrospray injection tandem mass spectrometry method for fast, selective measurement of S-adenosylmethionine and S-adenosylhomocysteine in plasma. Clin Chem 51:1487-1492, 2005.
26. Reidy JA: Role of deoxyuridine incorporation and DNA repair in the expression of human chromosomal fragile sites. Mutat Res 200:215-220, 1998.
27. Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G: Impact of folate deficiency on DNA stability. J Nutr 132:2444S-2449S, 2002.
28. Balaghi M, Wagner C: DNA methylation in folate deficiency: use of CpG methylase. Biochem Biophys Res Commun 193:1184-1190, 1993.
29. Achón M, Alonso-Aperte E, Ubeda N, Varela-Moreiras G: Supranormal dietary folic acid supplementation: effects on methionine metabolism in weanling rats. Br J Nutr 98:490-496, 2007.
30. Fux R, Kloor D, Hermes M, Rock T, Proksch B, Grenz A, Delabar U, Bucheler R, Igel S, Mörike K, Gleiter CH, Osswald H: Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers. Am J Physiol Renal Physiol 289:F786-F792, 2005.
31. Pufulete M, Al-Ghnaniem R, Khushal A, Appleby P, Harris N, Gout S, Emery PW, Sanders TA: Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 54:648-653, 2005.
32. Friso S, Lamon-Fava S, Jang H, Schaefer EJ, Corrocher R, Choi SW: Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women. Br J Nutr 97:617-621, 2007.
33. Craig SA: Betaine in human nutrition. Am J Clin Nutr 80:539-549, 2004.
34. Baric I, Fumic K, Glenn B, Cuk M, Schulze A, Finkelstein JD, James SJ, Mejaski-Bosnjak V, Pazanin L, Pogribny IP, Rados M, Sarnavka V, Scukanec-Spoljar M, Allen RH, Stabler S, Uzelac L, Vugrek O, Wagner C, Zeisel S, Mudd SH: S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A 101:4234-4239, 2004.
35. Basten GP, Duthie SJ, Pirie L, Vaughan N, Hill MH, Powers HJ: Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers. Br J Cancer 94:1942-1947, 2006.
36. Sweeney MR, McPartlin J, Scott J: Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health 7:41, 2007.
37. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, Oral E, Potter JD, Ulrich CM: Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 136:189-194, 2006.
38. Sauer J, Mason JB, Choi SW: Too much folate: a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 12:30-36, 2009.
39. Woo KS, Chook P, Chan LL, Cheung AS, Fung WH, Qiao M, Lolin YI, Thomas GN, Sanderson JE, Metreweli C, Celermajer DS: Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 112:535-539, 2002.
40. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J: Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105:22-26, 2002.
41. Devlin AM, Arning E, Bottiglieri T, Faraci FM, Rozen R, Lentz SR: Effect of MTHFR genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 103:2624-2629, 2004.
42. Friso S, Choi SW: Gene-nutrient interactions and DNA methylation. J Nutr 132:2382S-2387S, 2002.
43. Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF: Folic acid intake from fortification in United States exceeds predictions. J Nutr 132:2792-2798, 2002.
44. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ: Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82:442-450, 2005.
45. Bazzano LA, Reynolds K, Holder KN, He J: Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296:2720-2726, 2006.
46. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578-1588, 2006.
47. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 35:1567-1577, 2006.